MDXH MDxHealth, Inc.: שווי הפעילות העסקית

MDxHealth SA (MDXH) delegates data storage to cloud services while maintaining control over biomarkers and laboratories. This protects the business from risks while complying with strict FDA regulations and holding patents for its tests. This chart reflects a market valuation of 105.22. MDxHealth SA (MDXH) is establishing the standard for prostate cancer diagnostics by integrating genetic research into urological protocols to minimize unnecessary biopsies.

The stability of cash flows for MDxHealth SA (MDXH) depends on the adoption rate of oncourological tests into insurance protocols, which directly impacts the business's capitalization. By analyzing the company's EV, an investor sees the total acquisition cost of the asset, calculated as the sum of the market price of shares and net debt, allowing for an assessment of the business's real price inclusive of all liabilities.